XML 24 R13.htm IDEA: XBRL DOCUMENT v3.25.4
Intangible Assets, Net
 6 Months Ended
Dec. 31, 2025
Intangible Assets, Net [Abstract]  
INTANGIBLE ASSETS, NET

NOTE 8 — INTANGIBLE ASSETS, NET

 

Net intangible assets consist of the following:

 

   December 31,
2025		   June 30,
2025		 
License  $418,867   $418,867 
Less: accumulated amortization   (96,169)   (53,427)
Intangible asset, net  $322,698   $365,440 

 

On November 5, 2024, the Company purchased a license of pharmaceutical distribution in Mainland China through its acquisition of 100% equity interest in Hupan Pharmaceutical. The Company recognized the distribution license as an intangible asset of $418,867 based on the assessment of fair value at the purchase date, adjusted by deferred taxes impact on temporary tax differences in an asset acquisition using the simultaneous equations method. The transaction was closed on November 21, 2024. No impairment expense was recognized for the six months ended December 31, 2025. 

 

Amortization expense of $21,371 was recognized for the three months ended December 31, 2025. Amortization expense of $42,742 was recognized for the six months ended December 31, 2025.